固定化啤酒酵母废菌体吸附Pd2+的研究

用2％海藻酸钠与l％明胶混合为包埋剂固定啤酒酵母废菌体。SEM、X-射线能谱和TEN研究结果表明,该固定化啤酒酵母废菌体(ISCWB)颗粒中的菌体分布较均匀,ISCWB不仅能吸附Pd^2 ,而且能将Pd^2 还原成Pd^0。ISCWB吸附Pd^2 的最适pH值为3．5。在30℃～70℃范围内,吸附作用不受温度的影响。吸附作用是一个较快的过程,在最初的5min内吸附量可达最大吸附量的36％。吸附作用受ISCWB浓度、Pd^2 起始浓度和共存离子的影响。在起始Pd^2 浓度100mg/L,ISCWB浓度1．8g/L、pH3．5和30℃条件下振荡吸附90min,吸附量为40．6mg/g.以0．5mol／L盐酸作为解吸剂解吸率达98．7％。连续吸附与解吸附试验结果表明,ISCWB的最大饱和吸附量为46．3mg/g,解吸率为98％。     

固定化地衣芽孢杆菌R08吸附Pd2+的研究

比较了四种固定菌体的方法。结果以聚乙烯醇—海藻酸钠包埋地衣芽孢杆菌(Bacillus licheniformis)R08菌体,制成直径约2mm的颗粒,然后用磷酸缓冲液处理,5%戊二醛溶液交联,制得的固定化R08菌体(PIRB)对Pd²⁺的吸附率最高。PIRB吸附Pd²⁺的最适pH值为35。吸附作用是一种迅速的过程。在5℃～60℃范围内,吸附作用不受温度的影响。溶液中的PIRB含量和Pd²⁺起始浓度影响吸附作用,在05gPIRB/L、200mg Pd²⁺/L、pH35和30℃条件下,吸附60min,吸附量达94.7mg/g干重。吸附过程符合Freundlich和Langmuir吸附等温式。Au³⁺等离子抑制PIRB对Pd²⁺的吸附。用lmol/L HCl洗脱PIRB所吸附的Pd²⁺,解吸率为83.6%。在填充床反应器中,在流速2mL/min、100mgPd²⁺/L、2.5g PIRB(干重)、pH3.5和30℃条件下,反复吸附-解吸附,最初5批的饱和吸附量、吸附率和解吸率分别平均为44.3mgPd2+/g干重、89.4%和82.5%。在与上述相同的条件下,PIRB对废钯催化剂处理液中的Pd2+的吸附量为41.3mg/g,吸附率为88.6%。     

细菌吸附Pd2+的研究

从不同来源的细菌菌株中筛选获得一株吸附Pd²⁺能力较强的菌株R08,经鉴定为地衣芽孢杆菌(\%Bacillus licheniformis)\%R08。R08死菌体吸附Pd²⁺的最适pH值为3.5,其吸附作用是一种快速而非依赖温度的过程。吸附作用受菌体浓度和Pd²⁺浓度影响。在起始Pd²⁺浓度200mg/L\,菌浓度0.4g/L\,pH35和30℃条件下,吸附45min,吸附量为2248mg/g。透射电镜观察显示,R08死菌体能够还原Pd²⁺成Pd0颗粒。红外光谱分析表明,细胞壁上的COO－和ＨＰＯ４２－基团可能与Pd²⁺的生物吸附有关。     

巨大芽孢杆菌D01吸附金(Au3+)的研究

巨大芽孢杆菌(Bacillus megaterium)D01菌体吸附Au3+的最适pH值为30,其生物吸附作用是一种快速的过程,最初5min的吸附量可达到最大吸附量的95%,温度不影响该吸附作用。在pH3.0和30℃、起始金离子浓度与菌体浓度之比为305mg/g的条件下,吸附30min,吸附率达99.1%,吸附量为302.0mg/g干菌体。D01菌体能将溶液中的Au3+还原成Au0,在细胞表面和溶液中的Au0能形成不同形状的金晶体。浸渍在SiO2和αFe2O.3的Au3+能被D01菌体还原成Au0。从电化学反应表明,D01菌体对Au3+的还原具有较好的选择性。     

用固定化弗劳地柠檬酸杆菌XP05从溶液中回收铂

比较了5种固定弗劳地柠檬酸杆菌XP05菌体的方法,其中明胶海藻酸钠包埋法为固定菌体的最佳方法。扫描电子显微镜观察表明,XP05菌体较均匀地分布于包埋基质中。固定化XP05菌体吸附Pt^4＋受吸附时间、固定化菌体浓度、溶液的pH值和Pt^4＋起始浓度的影响。吸附作用是一个快速的过程;吸附Pt^4＋的最适pH值为1.5;在50～250 mg P^4＋/L范围内,吸附量与Pt^4＋起始浓度成线性关系,吸附过程符合Langmuir和Freundlich吸附等温模型。在Pt^4＋起始浓度250 mg/L、固定化菌体2.0 g/L、pH 1.5和30℃条件下,振荡吸附60 min, 吸附量为35.3 mg/g。0.5 mol/L HCl能使吸附在固定化菌体上的Pt解吸98.7%。从废铂催化剂处理液回收铂的结果表明,在Pt^4＋起始浓度111.8 mg/L、固定化菌体4.0 g/L、pH 1.5和30℃条件下,振荡吸附60 min, 吸附量为20.9 mg/g。在填充床反应器中,在Pt^4＋起始浓度50 mg/L、流速1.2 ml/min、固定化菌体1.86 g的条件下,饱和吸附量达24.7 mg/g; 固定化XP05菌体经4次吸附解吸循环后吸附率仍达78％。     

红螺菌对Cu2+的吸附研究

研究了4株红螺菌(R-01,R-02,R-03,R-04)对Cu^2 的生物吸附行为。结果表明,3株红螺菌(R-01,R-02,R-04)对20mg／L的Cu^2 有较高的吸附率,其中R-04达99．1％。进一步研究了R-04菌体的最佳吸附条件,在pH2、浓度为80mg／L Cu^2 、35℃、微光厌氧下吸附45min,吸附率、吸附量分别达94％,48．08mg／g。在一定的浓度范围内红螺菌对Cu^2 的吸附符合Langmuir吸附模型和Freundlich吸附模型,但符合Langmuir吸附模型的程度更优。     

酵母菌Y17吸附Cu2+的影响因素及吸附机理研究

以高效吸附Cu2+的酵母菌Y17为材料, 对其吸附Cu2+过程中的主要影响因素, 包括溶液pH、Cu2+初始浓度、菌体添加量、吸附时间和温度以及吸附机理进行了探讨。结果表明, 对吸附过程影响较大的因素依次为吸附液pH值、Cu2+初始浓度、菌体添加量和吸附时间。正交试验得到最佳吸附条件为溶液pH5.0, 吸附时间40 min, 加菌量5.0 g湿菌/L时, 对初始浓度为8 mmol/L的Cu2+达到最佳吸附率为82.7%。通过对Y17菌体不同处理及解吸实验, 初步确定Y17吸附Cu2+的位点在细胞壁, 细胞壁表面的-NH2, -COOH基团在其吸附过程中起着重要作用。     

羰基还原酶不对称还原（R）-6-氰基-5-羟基-3-羰基己酸叔丁酯

选择R-羰基还原酶和葡萄糖脱氢酶双酶,协同催化（R）-6-氰基5-羟基-3-羰基己酸叔丁酯不对称还原制备阿托伐他汀关键手性合成子6-氰基-（3R,5R）-二羟基已酸叔丁酯。转化条件优化结果显示：在不添加外源性辅酶NADP（H）、菌体用量15．0g/L、147．0g/L（R）-6-氰基-5-羟基-3-羰基己酸叔丁酯、128．2g／L葡萄糖,30℃、pH6．5条件下反应6h后,底物转化率达到100％,产物d．e．值大于99．5％。     

球衣菌对工业废水中Cu2+吸附条件的研究

利用球衣菌FQ32制备生物吸附剂,研究其对Cu^2＋的耐受能力,并以连江某工厂含Cu^2＋废水为样液,对其进行吸附条件试验,分析了影响吸附率和吸附量的因素,结果表明,球衣菌FQ32对Cu^2＋的耐受能力大于150mg／L。在工业废水中Cu^2＋的浓度为23．1mg／L,吸附剂用量为0．2g／L,30℃,pH值6．0,吸附时间10min的条件下,该吸附剂对Cu^2＋的吸附率达到85．2％,吸附量达91．21mg／g。     

出芽短梗霉菌JB16铅镉吸附特性的研究北大核心

【目的】本文对污染土壤中的耐重金属菌株进行分离鉴定,研究菌株在不同条件下对吸附铅镉的影响因素。【方法】通过生理生化特征及ITS序列分析确定菌株种属,采用平板划线法确定最大耐铅镉浓度并探究菌株吸附的最佳条件;通过准二级动力学、Langmuir和Freundlich等温吸附的模型及红外光谱探究吸附过程。【结果】菌落形态和ITS序列分析鉴定表明,筛选分离的JB16为出芽短梗霉菌(Aureobasidium pullulans),最大耐铅浓度达1500 mg/L,最大耐镉浓度达750 mg/L,最大耐铅镉混合浓度达1500 mg/L和300 mg/L。通过单因素实验(温度、时间、菌龄、pH、湿菌体浓度和初始重金属浓度)得出结论,在温度30℃、时间2 h、菌龄72 h、pH 6、湿菌体浓度5 g/L和初始铅浓度150 mg/L的最佳条件下,菌体对铅的吸附率为88.5%;在温度30℃、时间1 h、菌龄96 h、pH 6、湿菌体浓度5 g/L和初始镉浓度20 mg/L的最佳条件下,菌体对镉的吸附率为59.4%。菌株吸附铅镉过程符合Langmuir吸附模型和准二级动力学模型,为表面单分子层吸附。扫描电镜和红外光谱分析表明,重金属离子对菌体造成影响,吸附前后形态发生变化,细胞表面的羟基、羧基、饱和C−H键和酰胺基等基团参与了吸附过程。【结论】菌株JB16具有一定的铅镉吸附效果,为修复重金属铅镉污染的水体和土壤提供宝贵的菌种资源和数据支持。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).